Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.60    -0.025 (-4.00%)
Bid:
0.55
Ask:
0.65
Spread: 0.10 (18.182%)
Market Cap: £2.72m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Trading Update

4 Jul 2012 15:25

RNS Number : 9352G
Physiomics PLC
04 July 2012
 



Physiomics plc

 

(the "Company")

 

Trading Update

 

The Company confirms today that, as a consequence of some anticipated projects being delayed, its results for the year ended 30 June 2012 are likely to fall below current management expectations.

 

Mark Chadwick, CEO of Physiomics explained "While general market conditions and project delays have meant that revenues have not been realised as quickly as we would have wanted, the Company remains well funded for the next 12 months. The potential for new projects remains high with a number of large pharmas and biotech companies. In addition, our new product development projects are progressing apace." 

 

Enquiries:

 

Physiomics plc

Mark Chadwick 

+44 (0)1865 784980

 

WH Ireland Limited

Katy Mitchell

+44 (0) 161 832 2174

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPMUPPGCC
Date   Source Headline
10th Nov 20233:14 pmRNSBusiness Update Presentation
10th Nov 20237:00 amRNSInnovate UK grant award
18th Oct 20237:00 amRNSNotice of AGM
4th Oct 20237:00 amRNSChange of Registered Office
3rd Oct 20237:00 amRNSSenior Management Announcement
28th Sep 20237:00 amRNSAnnual Financial Report
4th Sep 20237:00 amRNSSenior Management Update
31st Aug 20231:00 pmRNSContract Award
31st Aug 20237:00 amRNSContract Award
8th Aug 20237:45 amRNSContract Award
4th Aug 20237:00 amRNSContract Award
25th Jul 20237:00 amRNSDirector Dealing
18th Jul 20237:00 amRNSDirector Dealing
29th Jun 20237:00 amRNSCompletion of Placing, Subscription & Retail Offer
27th Jun 20237:01 amRNSWRAP Retail Offer for up to £150,000
27th Jun 20237:00 amRNSCompletion of Equity Fundraise
31st May 20237:00 amRNSCollaboration with The University of Sheffield
23rd May 20237:00 amRNSTrading Update
9th May 20237:00 amRNSPublication of article in Frontiers in Oncology
26th Apr 20237:00 amRNSCollaborative Services Agreement
14th Apr 20237:00 amRNSPhysiomics to present at AACR Annual Meeting
4th Apr 20237:00 amRNSTrading and Company Update
28th Mar 20237:00 amRNSAnnouncement of Collaboration
10th Mar 20237:00 amRNSContract announcement
7th Mar 20237:00 amRNSInterim Results
13th Jan 20237:00 amRNSChange in role of board Director
11th Jan 20237:00 amRNSContract announcement
9th Jan 20237:00 amRNSCompletion of PARTNER study
22nd Nov 20224:00 pmRNSResult of AGM
10th Nov 20228:50 amRNSContract award
9th Nov 20227:00 amRNSPYC to present and exhibit at SITC Annual Meeting
27th Oct 20227:00 amRNSAnnual Report and AGM Notice
14th Oct 20227:00 amRNSConference Attendance
12th Oct 20227:00 amRNSContract Award
4th Oct 20227:00 amRNSContract Award
29th Sep 20227:00 amRNSInterim Results
9th Sep 20227:00 amRNSNotice of Results
1st Sep 20227:00 amRNSAppointment of Independent Non-Executive Director
7th Jul 20227:00 amRNSTrading update
4th May 20227:00 amRNSPhysiomics expands technical team
29th Apr 202210:00 amRNSIssue of Options
8th Apr 20227:00 amRNSContract award
29th Mar 20227:00 amRNSAppointment of Independent Non-Executive Director
7th Mar 20227:00 amRNSInterim Results
2nd Mar 20227:00 amRNSContract award
2nd Mar 20227:00 amRNSNotice of Interim Results & Investor Presentation
23rd Feb 20227:00 amRNSBoard Changes
21st Feb 202210:00 amRNSDoseMeRx Update
19th Jan 202212:30 pmRNSIssue of Equity
22nd Dec 202112:00 pmRNSContract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.